Perampanel: A selective AMPA antagonist for treating seizures

Gregory L. Krauss

doi:10.5698/1535-7597-13.6.269

Perampanel: A selective AMPA antagonist for treating seizures

Gregory L. Krauss

School of Medicine

Research output: Contribution to journal › Review article › peer-review

15 Scopus citations

Abstract

Perampanel is a selective, noncompetitive AMPA receptor antagonist that has recently been approved for treating localization-related epilepsy. This article reviews the pharmacology, clinical development, efficacy, and safety/tolerability of perampanel.

Original language	English (US)
Pages (from-to)	269-272
Number of pages	4
Journal	Epilepsy Currents
Volume	13
Issue number	6
DOIs	https://doi.org/10.5698/1535-7597-13.6.269
State	Published - Nov 2013

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.5698/1535-7597-13.6.269

Cite this

@article{3817bdea4f7a4e5ea35ec5539213cd16,

title = "Perampanel: A selective AMPA antagonist for treating seizures",

abstract = "Perampanel is a selective, noncompetitive AMPA receptor antagonist that has recently been approved for treating localization-related epilepsy. This article reviews the pharmacology, clinical development, efficacy, and safety/tolerability of perampanel.",

author = "Krauss, {Gregory L.}",

year = "2013",

month = nov,

doi = "10.5698/1535-7597-13.6.269",

language = "English (US)",

volume = "13",

pages = "269--272",

journal = "Epilepsy Currents",

issn = "1535-7597",

publisher = "American Epilepsy Society",

number = "6",

}

TY - JOUR

T1 - Perampanel

T2 - A selective AMPA antagonist for treating seizures

AU - Krauss, Gregory L.

PY - 2013/11

Y1 - 2013/11

N2 - Perampanel is a selective, noncompetitive AMPA receptor antagonist that has recently been approved for treating localization-related epilepsy. This article reviews the pharmacology, clinical development, efficacy, and safety/tolerability of perampanel.

AB - Perampanel is a selective, noncompetitive AMPA receptor antagonist that has recently been approved for treating localization-related epilepsy. This article reviews the pharmacology, clinical development, efficacy, and safety/tolerability of perampanel.

UR - http://www.scopus.com/inward/record.url?scp=84893007103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893007103&partnerID=8YFLogxK

U2 - 10.5698/1535-7597-13.6.269

DO - 10.5698/1535-7597-13.6.269

M3 - Review article

C2 - 24348124

AN - SCOPUS:84893007103

SN - 1535-7597

VL - 13

SP - 269

EP - 272

JO - Epilepsy Currents

JF - Epilepsy Currents

IS - 6

ER -

Perampanel: A selective AMPA antagonist for treating seizures

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this